Adverum Biotechnologies Inc.
ADVM | NASDAQ
$4.36
$0 (0.00%)
At close: Dec 9, 2025, 4:00 PM ET
Market Data
Market Cap $96.26M
Enterprise Value $159.14M
Beta 0.87
Average Volume 702.08K
Shares Outstanding (Diluted) 23.49M
Shares Change YoY 12.51%
Institutional Ownership 61.15%
Exchange NASDAQ
ISIN US00773U2078
Price Performance
Price Change 1M 4.8%
Price Change 3M 7.4%
Price Change 6M 69.0%
Price Change YTD -9.2%
Price Change 1Y -8.0%
Price Change 3Y N/A
Price Change 5Y -96.5%
1M CAGR (ann.) 2.8%
1Y CAGR (ann.) -23.4%
5Y CAGR (ann.) -50.0%
All-Time CAGR -30.7%
Valuation
PE Ratio -0.51
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.10
PS Ratio N/A
Forward PS 1.80
PB Ratio -1.73
P/FCF Ratio -0.70
P/Adj. FCF Ratio -0.66
P/OCF Ratio -0.93
EV/Sales N/A
EV/EBIT -0.78
EV/EBITDA -0.79
EV/FCF -1.15
Earnings Yield -196.8%
FCF Yield -143.8%
Adj. FCF Yield -151.7%
Financial Health
Net Cash $20.25M
Total Debt $88.94M
Cash & Short-Term Investments $26.06M
Total Assets $72.4M
Current Ratio 0.65
Quick Ratio 0.65
Debt / Equity Ratio -1.60
Debt / EBITDA -0.44
Debt / FCF -0.64
OCF / Debt -1.55
Interest Coverage 0.00
Altman Z-Score -32.54
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -5.5%
Returns
Return on Assets -198.7%
Return on Equity 872.8%
Return on Invested Capital -433.6%
Return on Capital Employed -524.7%
Return on Tangible Assets -198.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -117.4%
Revenue CAGR 5Y -57.9%
Revenue CAGR 10Y -3.0%
EPS CAGR 3Y -64.8%
EPS CAGR 5Y -46.5%
EPS CAGR 10Y -17.0%
FCF CAGR 3Y -23.7%
FCF CAGR 5Y 0.1%
FCF CAGR 10Y -11.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 16
EPS Growth Next 3Y 19.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2025
EPS Estimate (next Q) -$1.80
EPS Growth Est (next Q) 38.5%
Revenue Est (next Q) $200K
Revenue Growth Est (next Q) -80.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8.90
Price Target Upside 104.1%
Cash Flow
Operating Cash Flow $-137.9M
Free Cash Flow $-138.45M
Adj. Free Cash Flow $-146M
FCF Per Share -$4.69
OCF Per Share -$4.67
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-465K
Operating Income $-207.32M
EBITDA $-201.9M
Net Income $-204.39M
EPS (Diluted) -$8.58
Revenue / Employee N/A
Profit / Employee $-1.32M
Employees 155
Add to Watchlist
Select watchlists to add or remove ADVM